However, reports providing evidence for both suppression and induction of tumor formation (all depending on the specific tissues and the genetic background [154]) necessitate increased vigilance concerning the use of PTP1B inhibitors in cancer therapy. This evidence concerns the gene PTPN1 and cancer.